Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST
Published on February 25, 2020 in New York (N.Y.)
February 25, 2020 – New York – Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced that it will report the fourth quarter 2019 and year-end financial results on Wednesday, March 4, 2020, after the close of the US market. The announcement will be followed by a conference call at 7:30 AM EST / 1:30 PM CET on Thursday, March 5, 2020, prior to the open of the US market.
The live dial-in information for the conference call is:
US & Canada only: 877-407-3104
International: 201-493-6792
In addition, a replay of the call will be available until March 19, 2020 by calling 877-660-6853 (Toll Free US & Canada); 201-612-7415 (Toll Free International), Conference ID: 13688263